Vaccines List

ACI-35.030 is a first-in-class vaccine candidate designed to generate a specific antibody response against pTau proteins in the brain.Read more...

Ad26.Mos4.HIV is a tetravalent vaccine candidate containing recombinant adenovirus serotype 26 (Ad26) vectors with mosaic inserts.Read more...

Ad5-EBOV is an adenovirus type 5 vector-based Ebola virus disease vaccine that protects against Ebola virus disease.Read more...

AdCOVID COVID-19 vaccine candidate has been discontinued. Altimmune Inc.'s AdCOVID COVID-19 vaccine candidate was based on an adenovirus-based intranasal vaccine platform and expresses the receptor-binding domain of the SARS-CoV-2 spike protein.Read more...

AG0301 COVID-19 Vaccine candidate is a plasmid DNA vaccine that disables the connection between the protein spikes of the coronavirus and receptors in human cells.Read more...

Affinivax ASP3772 vaccine candidate is designed to offer protection against Streptococcus pneumoniae.Read more...

AV7909 is a combination of BioThrax (also called anthrax vaccine, adsorbed or AVA), an FDA-licensed vaccine, and CPG 7909.Read more...

Bacille Calmette-Guerin (BCG) vaccine is an attenuated, live culture preparation of the Bacillus of Calmette and Guerin strain of Mycobacterium bovis.Read more...

BBV154 is an intranasal viral vector vaccine that stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses.Read more...

Bexsero vaccine contains different proteins taken from group B Neisseria meningitidis bacteria.Read more...

BioNTech BNT111 Melanoma Vaccine candidate is a therapeutic melanoma cancer vaccineRead more...

BPZE1 is an intranasal vaccine candidate that consists of a live, attenuated form of the pertussis bacterium.Read more...

Brilacidin is a synthetic, non-peptidic small molecule that kills pathogens swiftly, significantly reducing the likelihood of drug resistance developing. Brilacidin also functions in a robust immunomodulatory capacity, lessening inflammation, and promoting healing.Read more...

BVRS-GamVac-Combi MERS Vaccine candidate is intended to prevent Middle East Respiratory SyndromeRead more...

Cervarix vaccine is a non-infectious recombinant, AS04-adjuvanted vaccine, that contains recombinant L1 protein, the major antigenic protein of the capsid, of oncogenic HPV types 16 and 18. Read more...

Chikungunya CHIKV-VLP vaccine is a multi-protein structure that mimics the organization and conformation of naturally occurring viruses, without the viral genome, which could potentially promote a stronger immune response and increased antibody production.Read more...

Clover COVID-19 Vaccine (SCB-2019) was developed by Clover Biopharma combining the trimeric SARS-CoV-2 spike (S)-protein with the company’s proprietary Trimer-Tag technology.Read more...

Convidicea (Ad5-nCoV) is a genetically engineered vaccine candidate with the replication-defective adenovirus type 5 as the vector to express SARS-CoV-2 spike protein.Read more...

CorbeVax COVID-19 Vaccine candidate (BioE COVID-19) is a protein subunit vaccine developed by Biological E. Limited in India.Read more...

Covaxin (BBV152) is an inactivated COVID-19 vaccine produced by Bharat Biotech. The SARS-CoV-2 virus strain was isolated from an asymptomatic COVID-19 patient at NIV, Pune. Read more...

COVI-VAC COVID-19 is a single-dose intranasal, live-attenuated vaccine candidate that is generated using Codagenix’s proprietary deoptimization technology.Read more...

CoviVac-Russia COVID-19 Vaccine is a Whole-virion vaccine that uses viruses that have already been killed (inactivated).Read more...

CTH522 is a Chlamydia vaccine candidate adjuvanted with CAF01 liposomes or aluminium hydroxide.Read more...

CureVac COVID-19 Vaccine (CVnCoV, CV2CoV) candidates utilize nucleotides without chemical modifications.Read more...

Delta gD-2 (∆gD-2) Herpes Vaccine candidate elicits antibodies that facilitate the killing of infected cells, which then rapidly clears the HSV-1 and HSV-2 viruses.Read more...

Diamyd® is an antigen-specific immunotherapy for the preservation of endogenous insulin production. Read more...

Ebanga (mAb114) (Ansuvimab) is a human IgG1 MAb targeted to the Zaire ebolavirus glycoprotein (GP).  Ebanga is a single monoclonal antibody that binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cells.Read more...

Encepur is a vaccine that consists of an inactivated and purified Tick-Borne Encephalitis (TBE) virus/strainRead more...

eOD-GT8 60mer HIV Vaccine candidate is designed to stimulate rare immune cells with specific properties. Read more...

Ervebo (rVSV-ZEBOV-GP) (v920) is a recombinant, replication-competent Ebola vaccine, consisting of a vesicular stomatitis virus that has been genetically engineered to express a glycoprotein from the Zaire ebolavirusRead more...

AstraZeneca Evusheld (AZD7442) (Tixagevimab / cilgavimab) is a Long-Acting Antibody combination engineered with proprietary half-life extension technology to increase the durability of the therapy.Read more...

Flu-v is a synthetic universal flu vaccine candidate offering long-lasting protection across a broad spectrum of influenza.Read more...

Fluarix Quadrivalent is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.Read more...

Flucelvax Quadrivalent (QIVc) is a cell culture-based flu vaccine to help offer protection against 4 flu virus strains identified for the current flu season.Read more...

FluMist (Fluenz Tetra) Quadrivalent is an Intranasal vaccine that is a live quadrivalent vaccine formulated to contain four influenza virus strains.Read more...

Gardasil vaccine consists of 4 proteins of HPV types 6, 11, 16, and 18, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water.Read more...

GEN-003 is an experimental immunotherapy vaccine comprised of 2 HSV-2 proteins, glycoprotein D2 and ICP4.2, and Matrix-M2 adjuvant (M2).Read more...

GEO-LM01 is a vaccine candidate that is based on the Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform, which generates noninfectious VLPs in the individual being vaccinatedRead more...

Havrix vaccine is a sterile suspension of inactivated virus strain HM175 which is propagated in MRC-5 human diploid cells.Read more...

HBAI20 vaccine candidate consists of a standard HBV vaccine to which the AI20 adjuvant is added. The adjuvant is able to give an additional stimulus to the immune system and may provide sufficient protection against HBV for the non-responders.Read more...

Hepatitis vaccines treat inflammation of the liver. There are 5 main hepatitis viruses, referred to as types A, B, C, D and E.Read more...

HER-Vaxx (IMU-131) is a B-cell peptide immunotherapy cancer vaccine candidate which is constructed from several B cell epitopes derived from the extracellular domain of HER-2/neu. Read more...

HGCO19 COVID-19 Vaccine is India's first indigenous messenger RNA (mRNA) vaccine.Read more...

Vaccination against human papillomavirus (HPV) is recommended to prevent new HPV infections and HPV-associated diseases, including cancers.Read more...

Sanofi Pasteur HSV529 is a herpes vaccine candidate is classified as a replication-defective virus, where the virus possesses all the components of the wild-type HSV virus with the exception of two proteins UL5 and UL29 that are involved in viral DNA replication.Read more...

ImmuneFx is a therapeutic vaccine candidate which expresses a bacterial antigen on the surface of a patient’s own tumor cells. IFx primes and educates the immune system to destroy tumor cells throughout the body without harming healthy cells and tissues.Read more...

Infanrix is a vaccine indicated for immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks.Read more...

Inmazeb (REGN-EB3) is an investigational triple antibody cocktail treatment for Ebola virus infectionRead more...

INO-4500 is a DNA vaccine candidate to prevent Lassa Fever.Read more...

INO-4800 is a DNA vaccine candidate matched to the SARS-CoV-2 Coronavirus which causes COVID-19.Read more...

IPOL vaccine is a highly purified, inactivated poliovirus vaccine with enhanced potency.Read more...

IVT-25 Pneumococcal Vaccine is an investigational conjugate vaccine to prevent pneumococcal bacterial infections.Read more...

Ixiaro is an inactivated, adsorbed Vero cell culture-derived preventive vaccine against the Japanese encephalitis virus and is prepared by propagating JEV strain SA14-14-2 in Vero cells.Read more...

JENVAC is an inactivated vero cell-derived vaccine prepared from an Indian Kolar strain of the Japanese encephalitis virus.Read more...

Kinrix (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) is a noninfectious, sterile vaccine for intramuscular administrationRead more...

Lyme PrEP Antibody Treatment delivers a single anti-Lyme antibody directly to a person.Read more...

M-M-R II vaccine is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus MMR vaccine.Read more...

Pfizer’s pentavalent meningococcal vaccine candidate (PF-06886992) combines its two approved meningococcal vaccines, Nimenrix™ (meningococcal group A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B vaccine).Read more...

Meningococcal vaccines prevent illness caused by bacteria called Neisseria meningitidis, also known as meningococcus. These illnesses are often severe and can be deadly.Read more...

MK-7110 (CD24Fc) COVID-19 Therapeutic candidate is a first-in-class recombinant fusion protein that targets the innate immune system.Read more...

Mosquirix (RTS,S/AS01e) is a recombinant malaria vaccine consisting of the P. falciparum circumsporozoite protein from the pre-erythrocytic stage.Read more...

mRNA-1345 Respiratory Syncytial Virus (RSV) Vaccine candidate encodes for a prefusion F glycoprotein, which elicits a superior neutralizing antibody response.Read more...

mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...

Moderna's mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.Read more...

Sanofi's MRT5400 and MRT5401 are mRNA Influenza Vaccine candidates that are entering a phase 1 clinical trial.Read more...

MV-CHIK is a vaccine candidate utilizing Themis’ measles vector platform. MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins.Read more...

MVA-MERS-S (Modified Vaccinia virus Ankara) is a vaccine candidate that contains the full-length spike gene of MERS-CoV.Read more...

MVA-M1+NP vaccine candidate consists of MVA, a replication-deficient pox viral vector that has been safely tested in thousands of patients, to generate a strong immune reaction against Matrix 1 (M1) and Nucleoprotein (NP) influenza antigens. Read more...

MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune responseRead more...

NanoVax is an adjuvant platform used in the development of a vaccine candidate that will provide protection against the two viruses that can cause genital herpes. Read more...

NEO-PV-01  Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...

Nirsevimab is a vaccine candidate that is a first-in-class single-dose immunization to provide protection for all infants entering their first RSV seasonRead more...

Novavax's Nuvaxovid COVID-19 vaccine (NVX-CoV2372) (Covovax) is a protein-based vaccine candidate engineered from the genetic sequence of the first strain of SARS-CoV-2.Read more...

PAXLOVID PF-07321332 is an oral antiviral protease inhibitor that demonstrates potent in vitro anti-viral activity.Read more...

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.Read more...

Pentacel vaccine consists of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component as well as an ActHIB® vaccine component Read more...

Plaquenil (hydroxychloroquine) is used to prevent or treat malaria, and for certain rheumatoid arthritis, systemic lupus erythematosus, and porphyria cutanea trade therapies.Read more...

Pneumosil is indicated against invasive disease, pneumonia, and acute otitis media caused by 10 Streptococcus pneumoniae serotypes in infants and toddlers from 6 weeks up to 2 years of age.Read more...

PreHevbrio (Sci-B-Vac) is a licensed, third-generation hepatitis B trivalent vaccine that mimics all three surface antigens, pre-S1, pre-S2, and S, of the hepatitis B virus (“HBV”).Read more...

Pfizer PREVNAR 20 is a 20-Valent pneumococcal conjugate vaccine to help protect adults 18 years and older from a substantial invasive pneumococcal disease and pneumonia burdenRead more...

ProQuad (MMRV) vaccine is a combined, attenuated, live virus vaccine containing measles, mumps, rubella, and includes varicella (MMRV) viruses.Read more...

R21 / Matrix-M vaccine candidate appears safe and very immunogenic in African children and demonstrates promising high-level efficacy.Read more...

The rabies vaccine is used to prevent rabies. There are several rabies vaccines available worldwide that are both safe and effective.Read more...

RAPIVAB (peramivir injection) is an influenza virus neuraminidase inhibitor.Read more...

Redeeflu (M2SR) is a nasal vaccine candidate utilizing a proprietary M2 deleted, single replication (M2SR) influenza virus.Read more...

ResVax is a vaccine candidate composed of recombinant RSV F nanoparticles adsorbed to aluminum phosphate.Read more...

RiVax Ricin Toxin Vaccine is Soligenix's proprietary heat stable recombinant subunit vaccine developed to protect against exposure to ricin toxin.Read more...

Rotasiil is a live attenuated oral Rotavirus Vaccine for the prevention of gastroenteritisRead more...

RSV preF - Pfizer RSV Vaccine candidate is based on the prefusion form of the RSV fusion proteinRead more...

RV144 is an HIV vaccine candidate that combines two different vaccine types: a prime and a booster.Read more...

Sabin Inactivated Poliovirus Vaccine is a liquid trivalent vaccine produced from Sabin poliovirus type 1, 2, and 3 strains grown on Vero cells. Read more...

GSK Shingrix adjuvanted recombinant zoster vaccine consists of the varicella-zoster virus glycoprotein E antigen and the AS01B adjuvant system, and a proprietary adjuvant containing QS-21 and MPL with liposomes.Read more...

Sinovac's PPV23 Pneumococcal Vaccine consists of 23 pneumococcal serotypes that are most frequently found in China.Read more...

Sotrovimab Xevudy (VIR-7831, GSK4182136) is a pan-sarbecovirus anti-SARS-CoV-2 monoclonal antibody treatement.Read more...

SpikeVax COVID-19 Vaccine Moderna (mRNA-1273, elasomeran) is an mRNA vaccine targeting SARS-CoV-2 encoding for a prefusion stabilized form of the Spike (S) protein.Read more...

Sputnik M vaccine (Gam-COVID-vac M) for children has the same components as Sputnik V but is 1/5 of the dose. Read more...

Stamaril is a live, attenuated vaccine that contains the active substance Yellow fever virus 17D-204 strain produced in specified pathogen-free chick embryos.Read more...

TAK-003 is a live attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus produced by Takeda Pharmaceutical Company Limited.Read more...

TAK-426 (PIZV) is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.Read more...

TG4001 is a therapeutic cancer vaccine candidate using an attenuated and modified poxvirus as a vector expressing the HPV16 E6 and E7 proteins and interleukin-2. Read more...

Pfizer TicoVac is a vaccine indicated to prevent tick-borne encephalitis TBE in individuals one year of age and older.Read more...

Trumenba is a sterile suspension composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).Read more...

TY014 will be the first therapeutic monoclonal antibody specifically targeting the Yellow Fever Virus to enter clinical trials.Read more...

Typhim VI protects against the risk of infection related to Salmonella typh i but it does not confer vis-à-vis protection of Salmonella Paratyphi A or B, or non-typhoid salmonella.Read more...

Ultimovacs UV1 is a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase.Read more...

V591 SARS-CoV-2 vaccine candidate uses a measles virus vector platform to deliver the antigens to the immune system to spur antibody production against SARS-CoV-2Read more...

Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...

Vaxart oral COVID-19 VXA-CoV2-1 is an oral tablet vaccine targeting both the spike protein (S) and nucleoprotein (N) of the novel SARS-CoV-2 coronavirus.Read more...

Vaxelis is a hexavalent (six-in-one) combination pediatric vaccine that includes antigens for diphtheria, tetanus, pertussis, and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from MerckRead more...

Vaxzevria AstraZeneca COVID-19 Vaccine (AZD1222) (ChAdOx1 nCov-19) (C19VAZ) (CovidShield) consists of the replication-deficient simian adenovirus vector ChAdOx1.Read more...

VBI-1901 is a cancer vaccine that VBI Vaccines has designed to treat glioblastoma multiforme and medulloblastoma, two types of brain tumors.Read more...

VC2 vaccine candidate is a live-attenuated, engineered version of HSV-1. The VC2 vaccine targets facial, ocular, and genital herpes caused by HSV-1 but may also protect against genital herpes caused by HSV-2. Read more...

VGX-3100 is an investigational immunotherapy vaccine that includes DNA plasmids targeting the E6 and E7 proteins of HPV types 16 and 18.Read more...

VIR-1111 HIV vaccine canidate is based on human cytomegalovirus that has been designed to elicit abundant T cells that recognize HIV epitopes in a way that differs from prior HIV vaccines.Read more...

Vivotif Oral contains live bacteria called Salmonella typhi strain Ty21a, which do not cause typhoid fever.Read more...

VPM1002  is a genetically modified BCG vaccine derived from the Mycobacterium bovis BCG subtype Prague characterized as rBCGÄureC::Hly+. Read more...

VTP-500 (ChAdOx1) MERS vaccine candidate treats MERS-CoV coronavirus utilizing the ChAdOx1 virus platform to encode MERS coronavirus spike protein in order to induce T cellsRead more...

Vyrologix (Leronlimab) is a CCR5 antagonist with the potential for multiple therapeutic indications including cancer, COVID-19, HIV and cancer.Read more...

Zifivax (ZF2001) is a protein subunit COVID-19 vaccine using a dimeric form of the receptor-binding domain (RBD) as the antigen, a harmless piece of the SARS-Cov-2 virus. Read more...

ZyCoV-D is a plasma DNA vaccine to fight COVID-19 disease.Read more...